The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 27, 2017
Filed:
Feb. 08, 2013
Applicant:
University of Virginia Patent Foundation, Charlottesville, VA (US);
Inventors:
Webster L. Santos, Blacksburg, VA (US);
Kevin R. Lynch, Charlottesville, VA (US);
Timothy L. Macdonald, Charlottesville, VA (US);
Andrew Kennedy, Charlottesville, VA (US);
Yugesh Kharel, Charlottesville, VA (US);
Mithun Rajendra Raje, Baltimore, MD (US);
Joseph Houck, Charlottesville, VA (US);
Assignee:
University of Virginia Patent Foundation, Charlottesville, VA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/04 (2006.01); C07D 413/06 (2006.01); C07C 257/14 (2006.01); C07C 257/16 (2006.01); C07C 275/70 (2006.01); C07C 279/16 (2006.01); C07C 279/18 (2006.01); C07C 281/16 (2006.01); C07C 251/02 (2006.01); C07C 251/12 (2006.01); C07C 271/20 (2006.01); C07C 279/00 (2006.01); C07D 249/08 (2006.01); C07D 263/32 (2006.01); C07D 271/06 (2006.01); C07D 271/10 (2006.01);
U.S. Cl.
CPC ...
C07D 413/04 (2013.01); C07D 413/06 (2013.01); C07C 251/02 (2013.01); C07C 251/12 (2013.01); C07C 257/14 (2013.01); C07C 257/16 (2013.01); C07C 271/20 (2013.01); C07C 275/70 (2013.01); C07C 279/00 (2013.01); C07C 279/16 (2013.01); C07C 279/18 (2013.01); C07C 281/16 (2013.01); C07C 2101/02 (2013.01); C07C 2101/14 (2013.01); C07D 249/08 (2013.01); C07D 263/32 (2013.01); C07D 271/06 (2013.01); C07D 271/10 (2013.01);
Abstract
The invention relates to inhibitors of Sphingosine Kinase enzymatic activity, and methods of treating diseases and disorders by administering inhibitors of Sphingosine Kinase enzymatic activity.